Pain Burden in Children and Adolescents With Cerebral Palsy

Summary

Pain in children and adolescents with cerebral palsy (CP) is a significant health challenge that so far has received too little attention. We lack knowledge on how pain is experienced, its consequences and of perceived support in managing pain. The overarching aim of the CPPain-program is to reduce pain experience, pain interference (e.g. pain burden) in children and adolescents living with CP. CPPain has a prospective cohort comparative design and will include before- and after measurements and process evaluation of a nested intervention.

This protocol concerns qualitative and quantitative data collection for the baseline of the CPPain program. The aim of the baseline data collection is to contribute in-depth knowledge of the pain burden in children and adolescents with CP. This knowledge is required to develop targeted pain-diminishing interventions in this vulnerable group of children with a high burden of challenges related to their chronic disease. In the next step, nested intervention will be co-created with children and adolescents with CP, their parents as well as health care professionals, and other professional caregivers involved in or responsible for management of pain based on existing research and baseline findings.

Conditions

• Cerebral Palsy

Interventions

OTHER

Co-created intervention

Sponsors & Collaborators

• Gillette Children's Specialty Healthcare

  collaborator OTHER

• IWK Health Centre

  collaborator OTHER

• The Hospital of Vestfold

  collaborator OTHER

• University of Oslo

  collaborator OTHER

• Oslo University Hospital

  collaborator OTHER

• University of Minnesota

  collaborator OTHER

• Örebro University, Sweden

  collaborator OTHER

• Dalhousie University

  collaborator OTHER

• Lund University

  collaborator OTHER

• Arcada University of Applied Sciences

  collaborator UNKNOWN

• Sykehuset Telemark

  lead OTHER_GOV

Principal Investigators

• Guro L. Andersen, PhD · The Hospital of Vestfold

Eligibility

Min Age

0 Years

Max Age

67 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-03-12

Primary Completion

2024-08-31

Completion

2024-08-31

Countries

• United States
• Canada
• Finland
• Norway
• Sweden

Study Locations